Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
Subscribe To Our Newsletter & Stay Updated
